Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le lundi 17 février 2020
Doi : 10.1016/j.jaad.2019.11.061
accepted : 26 November 2019
Regulations, liability, safety, and economics related to compounding

Elliott H. Campbell, MD a, , Dirk M. Elston, MD b, Chad L. Straughan, PharmD c, Diana D. Antonovich, MD d
a Indiana University School of Medicine, Indianapolis, Indiana 
b Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina 
c Tidewater Pharmacy & Medical Supply, Charleston, South Carolina 
d Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, South Carolina 

Correspondence to: Elliott H. Campbell, MD, 716 Timberline Dr, Villa Hills, KY 41017.716 Timberline Dr, Villa HillsKY41017

Extemporaneous compounding is a means to tailor a medication to an individual patient's needs and may be required when no commercial product exists to meet that need. Compounded products range from buffered lidocaine to topical creams and ointments. Recent heightened regulations have made compounding more challenging for dermatologists and prompted this review of regulations, liability, and safety related to compounding. With this information, providers may minimize liability and maximize safety while caring for their patients.

The full text of this article is available in PDF format.

Key words : botulinum toxin, compounding, cost, economics, financial, formulation, levigation, lidocaine, regulations, regulatory requirements, safety

Abbreviations used : FDA, USP

 Funding sources: None.
 Conflicts of interest: None disclosed.

© 2019  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline